Rho-kinase inhibitors in pseudophakic cystoid macular edema with secondary glaucoma

Indian journal of ophthalmology(2023)

引用 0|浏览4
暂无评分
摘要
Pseudophakic cystoid macular edema (PCME) is predominantly a self-limiting entity that can occasionally result in long-term visual deterioration. Rho-kinase (ROCK) inhibitors are therapeutic agents that have been successfully used for intraocular pressure (IOP) control in glaucoma patients and in the management of diabetic macular edema. In this report, we describe a case of mild nonproliferative diabetic retinopathy with PCME and secondary glaucoma. The patient presented with persistent PCME following scleral-fixated intraocular lens insertion, which was unresponsive to anti-vascular endothelial growth factor (anti-VEGF) agents and topical nonsteroidal anti-inflammatory therapy. A successful resolution of PCME was noted on 1-month follow-up after starting the patient on Rho-kinase inhibitors for secondary glaucoma.
更多
查看译文
关键词
pseudophakic cystoid macular edema,glaucoma,inhibitors,rho-kinase
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要